Skip to content
Medical Health Aged Care

Dementia Australia supports Limestone Coast

Dementia Australia 2 mins read

Are you concerned about your memory or worried that someone you know may have dementia? Dementia Australia is offering support in Limestone Coast between 18 September and 17 October.

It is estimated there are around 34,170 people living with all forms of dementia in South Australia. Without a medical breakthrough this number is expected to increase to more than 55,600 people living with dementia by 2054.

The Dementia Australia sessions are an opportunity for people living with dementia, their carers, family, and friends to attend free education to better understand dementia and to discuss the support and services Dementia Australia can provide. Please note, bookings are essential.

Worried About Your Memory?

This session provides information on memory and common changes that may occur with ageing. It provides strategies for improving memory, when to seek help about your concerns and services provided by Dementia Australia.

  • Wednesday 18 September, 10am-12pm ACST at Robe
  • Thursday 26 September, 10am-12pm ACST at Lucindale
  • Thursday 17 October, 10am-12pm ACDT at Naracoorte

Understanding Dementia

This session provides an introduction to dementia including an overview of different types of dementia, diagnosis, planning ahead and how to support someone living with dementia.

  • Wednesday 18 September, 1pm-3pm ACST at Robe
  • Thursday 26 September, 1pm-3pm ACST at Lucindale
  • Thursday 17 October, 1pm-3pm ACDT at Naracoorte

Bookings are essential. Visit https://www.dementia.org.au/get-involved/brain-hub/brain-hub-sa-limestone-coast for details and to register. You can also call the National Dementia Helpline to register for this course on 1800 100 500. The National Dementia Helpline is available 24 hours a day, seven days a week.

 

 

-Ends-

Dementia Australia is the source of trusted information, education and services for the estimated more than 421,000 Australians living with dementia, and the more than 1.6 million people involved in their care. We advocate for positive change and support vital research. We are here to support people impacted by dementia, and to enable them to live as well as possible. No matter how you are impacted by dementia or who you are, we are here for you.

For support, please contact the National Dementia Helpline on 1800 100 500. An interpreter service is available. The National Dementia Helpline is funded by the Australian Government. People looking for information can also visit dementia.org.au

Media contacts: Stephen O’Connell, Media & Communications Advisor, 0402 284 257, Stephen.oconnell@dementia.org.au

When talking or writing about dementia please refer to Dementia-Friendly Language Guidelines.

Note to Editors:

We request, where possible, details for the National Dementia Helpline 1800 100 500 appear alongside news stories about dementia, as these stories often prompt questions or concerns:

If this story has prompted any questions or concerns, please call the National Dementia Helpline 1800 100 500 (24 hours, 7 days a week) or visit dementia.org.au.

Media

More from this category

  • Medical Health Aged Care
  • 17/09/2024
  • 22:56
Ripple Therapeutics

Ripple Therapeutics Announces Collaboration and Option-to-License Agreement with AbbVie to Develop Next-Generation Therapies for Glaucoma Management

- Collaboration to leverage AbbVie's eye care expertise and Ripple's innovative drug delivery platform to develop next-generation sustained release drug delivery implants for the treatment of glaucoma TORONTO, ON / ACCESSWIRE / September 17, 2024 / Ripple Therapeutics today announced a collaboration and option-to-license agreement with AbbVie to develop RTC-620, a next generation, fully biodegradable, sustained release drug delivery intracameral implant with repeat dosing capabilities to reduce intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT). This collaboration leverages AbbVie's expertise in eye care and Ripple's innovative drug delivery platform.Ripple's patented technology platform is based on…

  • Medical Health Aged Care
  • 17/09/2024
  • 15:11
Galderma

Galderma Reaffirms Its Leadership in Dermatology With Extensive Presence at EADV 2024

Late-breaking presentations will reveal important new data from the phase III OLYMPIA and ARCADIA trials, including durability and long-term efficacy of nemolizumab in prurigo…

  • Contains:
  • Engineering, Medical Health Aged Care
  • 17/09/2024
  • 08:40
UNSW Sydney

New electricity-free soft robot could aid precise surgery

Biomedical engineers have developed a new soft robotic system that works without electricity or motors, allowing for more precise surgeries at lower cost. The…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.